Public Health Agency of Canada (PHAC) – Emerging Science Group (ESG) Evidence Reviews Evidence Brief on Protective Immunity Post Infection with Omicron July 26, 2022 Request PDF Evidence Brief on the associations and safety of COVID‑19 vaccination and post COVID‑19 condition, Update 2 July 7, 2022 Request PDF Evidence brief on attitudes and acceptance of COVID‑19 booster doses: update 1 April 1, 2022 Request PDF Evidence on the effectiveness and safety of ultraviolet germicidal irradiation technologies in reducing SARS-CoV-2 in the air of occupied rooms March 18, 2022 Request PDF Living Profile of SARS-CoV-2 Omicron (B.1.1.529) Variant of Concern Highlights up to February 16, 2022 February 16, 2022 Request PDF Evidence Brief on Parental and Adolescent Acceptance of COVID‑19 Vaccine for Those Aged 1-17 December 10, 2021 Request PDF Evidence Brief on the Risk of COVID‑19 Transmission in Flight, Update 3 November 25, 2021 Request PDF Evidence on the Virulence, Transmission and Impact of B.1.617.2 (Delta) among Children: Update 2, November 2021 November 19, 2021 Request PDF Rapid Review on Protective Immunity Post Infection with SARS-CoV-2, Update 3 October 22, 2021 Request PDF Rapid Review on Protective Immunity Post COVID‑19 Vaccination, Update 3 October 22, 2021 Request PDF Evergreen Rapid Review on COVID‑19 Vaccine Attitudes and Uptake in Canada – Update 11 October 18, 2021 Request PDF Living Summary of SARS-CoV-2 Variants of Concern: The Delta variant (B.1.617.2) profile Highlights up to September 15, 2021 September 15, 2021 Request PDF Evidence Brief of SARS-CoV-2 Incubation Periods August 17, 2021 Request PDF Living Summary of SARS-CoV-2 Variants of Interest: The C.37 (Lambda) Variant Profile Highlights up to August 10, 2021 August 10, 2021 Request PDF Living Summary of SARS-CoV-2 Variants of Concern: The Delta variant (B.1.617.2) profile, Highlights up to July 29, 2021 July 29, 2021 Request PDF Evergreen Rapid Review on COVID‑19 Vaccine Attitudes and Uptake, Update 8 July 14, 2021 Request PDF Living Summary of SARS-CoV-2 Variants of Concern: The Gamma variant (P.1) profile, Highlights up to July 1, 2021 July 1, 2021 Request PDF Living Summary of SARS-CoV-2 Variants of Concern: The B.1.1.7 (Alpha) Variant Profile Highlights up to July 1, 2021 July 1, 2021 Request PDF Living Summary of SARS-CoV-2 Variants of Concern: The Beta Variant (B.1.351) profile Highlights up to July 1, 2021 July 1, 2021 Request PDF Evidence Brief of Ivermectin June 23, 2021 Request PDF Evidence Brief on the Therapeutic use of Vitamin D Supplementation for COVID‑19 May 27, 2021 Request PDF Rapid Review on the Impact of School Closures and Re-openings on COVID‑19 Transmission May 4, 2021 Request PDF Evidence Brief on viral load and the likelihood of transmission during the infectious period of SARS-CoV-2 March 31, 2021 Request PDF Evidence Brief on SARS-CoV-2 Variants of Concern and Transmission in Children March 26, 2021 Request PDF Rapid Review on SARS-CoV-2 Aerosol Transmission, Update 2 March 12, 2021 Request PDF Evidence Brief of COVID‑19 Infectious Period in Immunosuppressed/ Immunocompromised Individuals February 17, 2021 Request PDF Evidence Brief of SARS-CoV-2 Risks in Arenas February 12, 2021 Request PDF Evidence Brief of SARS-CoV-2 contract tracing February 10, 2021 Request PDF Rapid Review of Multisystem Inflammatory Syndrome in Children (MIS-C) January 28, 2021 Request PDF Evidence brief of maximum incubation period January 26, 2021 Request PDF Evidence brief on adherence to isolation and quarantine recommendations during COVID‑19 January 20, 2021 Request PDF Rapid Review on the Characteristics of Effective Non-Medical Face Masks in Reducing the Risk of SARS-CoV-2 Transmission January 5, 2021 Request PDF Evidence brief of COVID‑19 quarantine length reduction strategies and effectiveness, Update 1 December 3, 2020 Request PDF Rapid review on the physiological effects of wearing face masks December 2, 2020 Request PDF Rapid review on the use of face masks to prevent COVID‑19 in community settings December 1, 2020 Request PDF Evidence on the clinical and epidemiological features of MIS-A associated with SARS-CoV-2 infection. November 13, 2020 Request PDF Evidence brief of potential health risks of hard-surface disinfectants in environments shared by school-aged children October 8, 2020 Request PDF Evidence brief on ethnicity and COVID‑19 September 22, 2020 Request PDF Rapid review on infectious period September 11, 2020 Request PDF Evidence brief on SARS-COV-2 antibodies in patients that retest RT-PCR positive September 9, 2020 Request PDF Evidence brief on the risk of COVID‑19 outbreaks in the workplace (update) August 25, 2020 Request PDF An evidence brief on SARS-CoV-2 transmission risks associated with playing non-professional sports August 20, 2020 Request PDF Rapid Review of COVID‑19 hospitalizations and length of stay August 20, 2020 Request PDF Evidence brief of size of gatherings and characteristics of high risk transmission events August 18, 2020 Request PDF COVID‑19 summary of heating, ventilation, air conditioning (HVAC) systems and transmission of SARS-CoV-2 August 14, 2020 Request PDF Evidence brief on the determinants of individual adherence to public health interventions for COVID‑19 July 23, 2020 Request PDF Evidence brief on age-dependent transmission July 22, 2020 Request PDF Evidence brief of pregnancy and severity of COVID‑19 July 17, 2020 Request PDF COVID‑19 summary of face shields to prevent transmission of SARS-CoV-2 July 7, 2020 Request PDF COVID‑19 summary of SARS-CoV-2 transmission and singing/wind Instruments July 5, 2020 Request PDF Evidence brief on SARS-CoV-2 virus dispersion distance June 24, 2020 Request PDF Evidence brief on the infection risk from eye exposures to inform contact and droplet precautions June 22, 2020 Request PDF Evidence brief of de-escalation of social bubbles June 19, 2020 Request PDF Evidence brief of aerosol generating procedures in dental care settings June 11, 2020 Request PDF Evidence brief on infectiousness and symptom onset June 4, 2020 Request PDF
Evidence Brief on the associations and safety of COVID‑19 vaccination and post COVID‑19 condition, Update 2 July 7, 2022 Request PDF
Evidence brief on attitudes and acceptance of COVID‑19 booster doses: update 1 April 1, 2022 Request PDF
Evidence on the effectiveness and safety of ultraviolet germicidal irradiation technologies in reducing SARS-CoV-2 in the air of occupied rooms March 18, 2022 Request PDF
Living Profile of SARS-CoV-2 Omicron (B.1.1.529) Variant of Concern Highlights up to February 16, 2022 February 16, 2022 Request PDF
Evidence Brief on Parental and Adolescent Acceptance of COVID‑19 Vaccine for Those Aged 1-17 December 10, 2021 Request PDF
Evidence Brief on the Risk of COVID‑19 Transmission in Flight, Update 3 November 25, 2021 Request PDF
Evidence on the Virulence, Transmission and Impact of B.1.617.2 (Delta) among Children: Update 2, November 2021 November 19, 2021 Request PDF
Rapid Review on Protective Immunity Post Infection with SARS-CoV-2, Update 3 October 22, 2021 Request PDF
Evergreen Rapid Review on COVID‑19 Vaccine Attitudes and Uptake in Canada – Update 11 October 18, 2021 Request PDF
Living Summary of SARS-CoV-2 Variants of Concern: The Delta variant (B.1.617.2) profile Highlights up to September 15, 2021 September 15, 2021 Request PDF
Living Summary of SARS-CoV-2 Variants of Interest: The C.37 (Lambda) Variant Profile Highlights up to August 10, 2021 August 10, 2021 Request PDF
Living Summary of SARS-CoV-2 Variants of Concern: The Delta variant (B.1.617.2) profile, Highlights up to July 29, 2021 July 29, 2021 Request PDF
Living Summary of SARS-CoV-2 Variants of Concern: The Gamma variant (P.1) profile, Highlights up to July 1, 2021 July 1, 2021 Request PDF
Living Summary of SARS-CoV-2 Variants of Concern: The B.1.1.7 (Alpha) Variant Profile Highlights up to July 1, 2021 July 1, 2021 Request PDF
Living Summary of SARS-CoV-2 Variants of Concern: The Beta Variant (B.1.351) profile Highlights up to July 1, 2021 July 1, 2021 Request PDF
Evidence Brief on the Therapeutic use of Vitamin D Supplementation for COVID‑19 May 27, 2021 Request PDF
Rapid Review on the Impact of School Closures and Re-openings on COVID‑19 Transmission May 4, 2021 Request PDF
Evidence Brief on viral load and the likelihood of transmission during the infectious period of SARS-CoV-2 March 31, 2021 Request PDF
Evidence Brief on SARS-CoV-2 Variants of Concern and Transmission in Children March 26, 2021 Request PDF
Evidence Brief of COVID‑19 Infectious Period in Immunosuppressed/ Immunocompromised Individuals February 17, 2021 Request PDF
Evidence brief on adherence to isolation and quarantine recommendations during COVID‑19 January 20, 2021 Request PDF
Rapid Review on the Characteristics of Effective Non-Medical Face Masks in Reducing the Risk of SARS-CoV-2 Transmission January 5, 2021 Request PDF
Evidence brief of COVID‑19 quarantine length reduction strategies and effectiveness, Update 1 December 3, 2020 Request PDF
Rapid review on the use of face masks to prevent COVID‑19 in community settings December 1, 2020 Request PDF
Evidence on the clinical and epidemiological features of MIS-A associated with SARS-CoV-2 infection. November 13, 2020 Request PDF
Evidence brief of potential health risks of hard-surface disinfectants in environments shared by school-aged children October 8, 2020 Request PDF
Evidence brief on SARS-COV-2 antibodies in patients that retest RT-PCR positive September 9, 2020 Request PDF
Evidence brief on the risk of COVID‑19 outbreaks in the workplace (update) August 25, 2020 Request PDF
An evidence brief on SARS-CoV-2 transmission risks associated with playing non-professional sports August 20, 2020 Request PDF
Evidence brief of size of gatherings and characteristics of high risk transmission events August 18, 2020 Request PDF
COVID‑19 summary of heating, ventilation, air conditioning (HVAC) systems and transmission of SARS-CoV-2 August 14, 2020 Request PDF
Evidence brief on the determinants of individual adherence to public health interventions for COVID‑19 July 23, 2020 Request PDF
Evidence brief on the infection risk from eye exposures to inform contact and droplet precautions June 22, 2020 Request PDF
